FAQ/Help |
Calendar |
Search |
Today's Posts |
08-03-2010, 06:18 AM | #1 | ||
|
|||
Magnate
|
|
||
Reply With Quote |
08-03-2010, 10:32 AM | #2 | ||
|
|||
Magnate
|
listened to company's conference call today, they believe better than stalevo. 2 phase3 trials, 1 on advanced pd, other moderate pd, results in mid 2011. a better controlled release sinemet wouldn't hurt.
http://phx.corporate-ir.net/External...xUeXBlPTM=&t=1 pg. 21 Last edited by soccertese; 08-03-2010 at 07:48 PM. |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Phase III: Pimavanserin In Patients With Parkinson's Disease Psychosis | Parkinson's Disease Clinical Trials | |||
Neurologix Announces Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease | Parkinson's Disease | |||
Neurologix completes all surgical procedures in Phase II Parkinson's disease study | Parkinson's Disease | |||
Impax Pharmaceuticals: Phase III trial of IPX066 in Parkinson’s Disease | Parkinson's Disease Clinical Trials | |||
Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's D | Parkinson's Disease |